BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8439262)

  • 1. Successful treatment of immobilization hypercalcemia using calcitonin and etidronate.
    Meythaler JM; Tuel SM; Cross LL
    Arch Phys Med Rehabil; 1993 Mar; 74(3):316-9. PubMed ID: 8439262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immobilization hypercalcemia associated with Landry-Guillain-Barré syndrome. Successful therapy with combined calcitonin and etidronate.
    Meythaler JM; Korkor AB; Nanda T; Kumar NA; Fallon M
    Arch Intern Med; 1986 Aug; 146(8):1567-71. PubMed ID: 3089187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin therapy in prolonged immobilization hypercalcemia.
    Carey DE; Raisz LG
    Arch Phys Med Rehabil; 1985 Sep; 66(9):640-4. PubMed ID: 4038033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immobilization hypercalcemia in acute spinal cord injury treated with etidronate.
    Merli GJ; McElwain GE; Adler AG; Martin JH; Roberts JD; Schnall B; Ditunno JF
    Arch Intern Med; 1984 Jun; 144(6):1286-8. PubMed ID: 6428341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypercalcemia due to immobilization in critically ill children: calcitnonin treatment].
    Urán Moreno M; Alonso Riofrío R; Moliner Robredo C; Pons Morales S; López-Herce Cid J
    An Esp Pediatr; 2001 Jun; 54(6):555-8. PubMed ID: 11412402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of clodronate on immobilization bone loss.
    Minaire P; Depassio J; Berard E; Meunier PJ; Edouard C; Pilonchery G; Goedert G
    Bone; 1987; 8 Suppl 1():S63-8. PubMed ID: 2961357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of a 24-hour infusion of etidronate disodium in the treatment of hypercalcemia of malignant disease. A dose-ranging pilot study.
    Flores JF; Singer FR; Rude RK
    Miner Electrolyte Metab; 1991; 17(6):390-5. PubMed ID: 1823390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous etidronate in the management of malignant hypercalcemia.
    Ryzen E; Martodam RR; Troxell M; Benson A; Paterson A; Shepard K; Hicks R
    Arch Intern Med; 1985 Mar; 145(3):449-52. PubMed ID: 3919667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective evaluation of the medical treatment of malignancy-associated hypercalcemia.
    Kimura S; Sato Y; Matsubara H; Adachi I; Yamaguchi K; Suzuki M; Suemasu K; Abe K
    Jpn J Cancer Res; 1986 Jan; 77(1):85-91. PubMed ID: 2937761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immobilization hypercalcemia in spinal cord injury.
    Maynard FM; Imai K
    Arch Phys Med Rehabil; 1977 Jan; 58(1):16-24. PubMed ID: 831659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M; Takami H
    Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immobilization hypercalcemia following spinal cord injury.
    Maynard FM
    Arch Phys Med Rehabil; 1986 Jan; 67(1):41-4. PubMed ID: 2935120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a 24-hour infusion of etidronate disodium for the treatment of hypercalcemia of malignancy.
    Flores JF; Rude RK; Chapman RA; Belani CP; Chang AY; Pritchard JD; Hoff JV
    Cancer; 1994 May; 73(10):2527-34. PubMed ID: 8174049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of oral administration of etidronate disodium in maintaining normal serum calcium levels in previously hypercalcemic cancer patients.
    Ringenberg QS; Ritch PS
    Clin Ther; 1987; 9(3):318-25. PubMed ID: 3111705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
    McMahan J; Linneman T
    Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe immobilization hypercalcemia, renal insufficiency, and calcification.
    Conley SB; Shackelford GD; Robson AM
    Pediatrics; 1979 Jan; 63(1):142-5. PubMed ID: 440790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of severe hypercalcemia.
    Davis KD; Attie MF
    Crit Care Clin; 1991 Jan; 7(1):175-90. PubMed ID: 2007213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthetic salmon calcitonin as an antihypercalcemic agent for hypercalcemia in malignancy].
    Adachi I; Kimura S; Yamaguchi K; Suzuki M; Abe K
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2637-44. PubMed ID: 3740862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypercalcemia in breast cancer].
    Okada Y; Ogawa M; Horikoshi N; Inagaki J; Inoue K; Ikeda K; Usui N; Nakada H; Adachi K; Mukaiyama T
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1468-74. PubMed ID: 6742868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.